How does long-term use of upadacitinib affect cancer incidence in patients with rheumatoid arthritis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18314020
Cited by: 0

Abstract

Long-term use of upadacitinib in rheumatoid arthritis may increase the risk of certain types of cancer, particularly non-melanoma skin cancer, compared to TNF inhibitors, based on available studies.

Fields of Study & Subjects

Rheumatoid Arthritis Research and Therapies Inflammatory mediators and NSAID effects Natural Compounds in Disease Treatment

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
20 January 2026